ASHLEY DOMINIQUE: Open Payments
NPI 1437454634 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 28 payments from 11 companies in 2025. Trend: 2023 $999 · 2024 $1,066 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $166 |
| Galderma Laboratories, L.P. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Botanix SB Inc | 2 | $48 |
| LEO Pharma Inc. | 2 | $47 |
| UCB, Inc. | 2 | $43 |
| STRATA Skin Sciences, Inc. | 1 | $36 |
| GENZYME CORPORATION | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $26 |
Products named: TREMFYA, NEMLUVIO, SOFDRA, ADBRY, Bimzelx, XTRAC, DUPIXENT, COSENTYX.
Industry payments across CA — which companies pay providers there.
